Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells
✍ Scribed by Wissniowski, Thadd�us
- Book ID
- 120023117
- Publisher
- Spandidos Publications Ltd
- Year
- 2012
- Tongue
- English
- Weight
- 776 KB
- Category
- Article
- ISSN
- 1019-6439
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Pancreatic cancer is one of the leading causes of cancerrelated death in Western countries. Bcl-x L is an anti-apoptotic factor of the Bcl-2 family, which is overexpressed in pancreatic cancer and its presence correlates with shorter patient survival. In this study, sequence-specific antisense oligo
## Abstract __This article has been retracted at the request of__: Editor‐in‐Chief and Co‐author ‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine‐resistant pancreatic cancer cells __in vitro__ and __in vivo__’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Set